Results for sanofi: 49

* Says all views on drug safety, efficacy should be heard * Says FDA not obliged to follow views of advisory panel NEW YORK, March 5 - The chief executive of Sanofi-Aventis suggested on Thursday...

SANOFI-AVENTIS SA, the biggest pharmaceutical company in Europe, announced yesterday it will strengthen e research and development presence in China with a newly signed partnership agreement with ...

* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA * Sanofi: materials appropriate, working with FDA (Adds company comment, paragraphs 6-7) WASHINGTON, May 13 - U.S. health regulators have cited Sanofi-Aventis...

* Sanofi heart drug should win US approval, reviewer says * Multaq should have limited claims - FDA reviewer memo * FDA panel to consider drug on Wednesday * Sanofi shares up 3 percent in...

* CEO says will fight against globalisation of business * Diversification and emerging markets key growth drivers LONDON, Nov 17 - French drugmaker Sanofi-Aventis sees major growth drivers in China and India but its chief...

CAMBRIDGE, Mass., Nov 10 - Production of H1N1 swine flu vaccine at two facilities in Pennsylvania is "working optimally," with output on the rise, the chief executive of Sanofi-Aventis SA said on Tuesday. The giant...

* Production on track with HHS agreements * Vaccine yields now running above expectations * No expectations for future production problems WASHINGTON, Oct 23 - U.S. health officials are struggling to deliver vaccine against the...

* Companies say drug deemed ineffective in Phase III study * Studies of aflibercept continue vs other cancer types * Regeneron stock down about 5 pct (Adds details on failed study, studies that continue) NEW...

* Say drug deemed ineffective in Phase III study * Studies of drug continue vs other cancer types NEW YORK, Sept 11 - Sanofi-Aventis and Regeneron Pharmaceuticals on Friday said they had halted a late-stage...

* FDA says journal reprint is misleading * Materials overstated Taxotere's benefits -FDA WASHINGTON, May 13 - U.S. health regulators have cited Sanofi-Aventis SA for circulating a reprinted journal article that overstated the benefits of...